Alkaline Phosphatase-To-Albumin Ratio (APAR) As A Prognostıc Biomarker in Metastatic Hormone-Sensitive Prostate Cancer
Year: 2026
Type: article
Study design: Observational Study
Abstract: Background: Metastatic hormone-sensitive prostate cancer (mHSPC) requires accessible biomarkers for better prognostication. This study investigated the prognostic value of the alkaline phosphatase-to-albumin ratio (APAR) in mHSPC survival risk stratification.Methods: We retrospectively analyzed 128 mHSPC patients. A cut-off of 2.92 for APAR was determined via ROC analysis. Overall survival (OS) was assessed using Kaplan–Meier methods and multivariable Cox regression adjusting for standard prognostic factors, including tumor volume and Gleason score.Results: Patients with APAR ≥2.92 had significantly shorter OS compared to those with APAR
Institution: Dokuz Eylül University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7162953833